Inositol

REVIVELE LAUNCHES COMPREHENSIVE WOMEN'S SUPPLEMENT SYSTEM

Retrieved on: 
Monday, October 23, 2023
Vitamin C, Grifola frondosa, Health, Menopause, DHA, Heart, Essential, Inositol, Digestion, Cordyceps, Vitamin, Conditional sentence, Absorption, Skin, Guess, Q10, Agaricus bisporus, Inflammation, Vitamin E, Pharming, EPA, Disease, Selenium, Immune system, Risk, Immunity, Mineral, Choline, Zinc, Chromium, Sleep, Capsule, Contract management, Melatonin, Brain, Woman, Bloom, Rhodiola, Pain management, Overalls, Fish, Nutrient, Hearing, Berberine, Sarah Hyland, Longevity, Dietary supplement, Nursing, Pharmacy, Alzheimer's disease

MIAMI, Oct. 23, 2023 /PRNewswire/ -- Revivele, the pharmacist-founded healthcare company empowering women to take control of their own health, has launched Essentials by Revivele, a comprehensive, easy-to-use supplement system tailored specifically to help improve and support women's overall health and longevity, especially as they enter their perimenopausal and post-menopausal years.

Key Points: 
  • Essentials by Revivele Takes the Guesswork out of Women's Supplementation with a System Designed to Support Cognitive Function, Balance Hormones, and Help Prevent Disease
    MIAMI, Oct. 23, 2023 /PRNewswire/ -- Revivele , the pharmacist-founded healthcare company empowering women to take control of their own health, has launched Essentials by Revivele , a comprehensive, easy-to-use supplement system tailored specifically to help improve and support women's overall health and longevity, especially as they enter their perimenopausal and post-menopausal years.
  • This strategic supplement system is also aimed at reducing the risk of chronic diseases like Alzheimer's, which affects twice as many women as men worldwide.
  • The Essentials by Revivele system is comprised of six daily products carefully formulated to work in harmony and be taken throughout the day.
  • For more information about Revivele and Dr. Desai, visit Revivele.com , or check out @Revivele.Inc on Instagram, Revivele.Inc on Facebook, and Revivele on LinkedIn.

Alterity Therapeutics Presents New Data on Multiple System Atrophy, a Rare Parkinsonian Disorder

Retrieved on: 
Thursday, August 31, 2023
PD, Multiple system atrophy, In vivo magnetic resonance spectroscopy, Pathology, Vanderbilt University Medical Center, Department of Neurology, Xuanwu hospital, ASX, Brain, Gliosis, Inositol, Movement disorder, Biomarker, Doctor of Philosophy, NAA, MDS, Congress, MRI, MRS, ATH, Patient, MSA, SAN, Diagnosis, Biomusic, Therapy, International Congress on Tuberculosis, MI, Disease, Medical imaging, Alterity, Neurology

MELBOURNE, Australia and SAN FRANCISCO, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that presentations from its bioMUSE natural history study of Multiple System Atrophy (MSA) were delivered at the International Congress of Parkinson’s Disease and Movement Disorders (MDS) taking place August 27 - 31, 2023 in Copenhagen, Denmark.

Key Points: 
  • The posters presented from Alterity’s bioMUSE study address the need for incorporating biomarkers as a critical component for diagnosis of MSA.
  • The diagnosis of early MSA can be challenging as individuals often present similarly to Parkinson’s disease (PD).
  • In contrast to PD, MSA is rapidly progressive and, therefore, it is vital to accurately diagnose patients enrolling in clinical trials.
  • The poster entitled, “A multimodal approach for diagnosis of early Multiple System Atrophy” was presented by Dr. Claassen.

LEADING WOMEN'S HEALTH BRAND O POSITIV LAUNCHES OVARIAN SUPPORT VITAMIN CAPSULES

Retrieved on: 
Wednesday, August 2, 2023
Inositol, Face, OBGYN, Woman, DIM, Scalp, Science, Hyperkinesia, PMS, Patient, PCOS, Health, Skin, FLO, Birth control

LOS ANGELES, Aug. 2, 2023 /PRNewswire/ -- Today, O Positiv, the women's health brand behind FLO, the first-ever PMS support supplement on the market, introduces their newest product FLO Ovarian Support Vitamin Capsules.

Key Points: 
  • LOS ANGELES, Aug. 2, 2023 /PRNewswire/ -- Today, O Positiv , the women's health brand behind FLO , the first-ever PMS support supplement on the market, introduces their newest product FLO Ovarian Support Vitamin Capsules .
  • Since launching the FLO PMS Gummy in December 2018, O Positiv has positioned themselves as a premiere wellness brand with a range of products to address vaginal, digestive, skin, menstrual and menopausal health.
  • Each FLO Ovarian Support Vitamin Capsule is formulated with the scientifically backed 40:1 ratio of Myo-Inositol and D-Chiro-Inositol to help support ovarian health and cycle regularity, folate to support reproductive health, and diindolylmethane (commonly known as DIM) to support healthy hormone levels.
  • "FLO Ovarian Support is great for patients who struggle with irregular cycles or overactive oil production on their face or scalp."

Sonesta Celebrates National Chocolate Chip Cookie Day With Nightfood Cookies

Retrieved on: 
Wednesday, August 2, 2023
Snack, Chocolate chip cookie, Perception, Sleep, Ice cream, Once You Give Away Your Heart, OTCQB, Sale, Hotels (magazine), Inositol, Hotel, Baking, Tourism, Sonesta

TARRYTOWN, NY AND NEWTON, MA, Aug. 02, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nightfood, Inc. (OTCQB: NGTF), the company pioneering the sleep-friendly nighttime snack category, announced today that Sonesta International Hotel Corporation (Sonesta) will celebrate National Chocolate Chip Cookie Day on August 4th by offering Nightfood’s sleep-friendly Prime-Time Chocolate Chip Cookies to guests checking in at select Sonesta locations.

Key Points: 
  • TARRYTOWN, NY AND NEWTON, MA, Aug. 02, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nightfood , Inc. (OTCQB: NGTF), the company pioneering the sleep-friendly nighttime snack category, announced today that Sonesta International Hotel Corporation (Sonesta) will celebrate National Chocolate Chip Cookie Day on August 4th by offering Nightfood’s sleep-friendly Prime-Time Chocolate Chip Cookies to guests checking in at select Sonesta locations.
  • “This is such a fun and delicious way to celebrate National Chocolate Chip Cookie Day,” stated Elizabeth Harlow, Sonesta’s Chief Brand Officer.
  • “Since we believe a good night’s rest is an important part of Sonesta’s guest experience, we will celebrate National Chocolate Chip Cookie Day by giving out cookies from Nightfood.”
    Nightfood cookies are formulated by sleep and nutrition experts to be a better choice for anybody snacking between dinner and bedtime.
  • Sonesta will be gifting Nightfood Prime-Time Chocolate Chip Cookies to guests checking in on August 4th at the following hotels:
    To learn more about Nightfood’s sleep-friendly cookies and ice cream, visit Nightfood.com .

Lo.Li. Pharma International and its International Partners Achieve a New World Record to Raise Awareness About Innovative Options for Managing PCOS and Infertility

Retrieved on: 
Wednesday, June 28, 2023
Inositol, ESHRE, Education, Society for Human Resource Management, Infertility, European Society of Human Reproduction and Embryology, Polycystic ovary syndrome, Patient, PCOS, Diagnosis, Pharmaceutical industry, Medical device, Embryology

The record-breaking event aimed to raise awareness about non-pharmacological options for managing polycystic ovary syndrome (PCOS) and infertility.

Key Points: 
  • The record-breaking event aimed to raise awareness about non-pharmacological options for managing polycystic ovary syndrome (PCOS) and infertility.
  • Inositol, a naturally occurring compound that plays a vital role in cellular signaling, has shown promise in managing PCOS and infertility.
  • This monumental achievement marks a significant step toward raising awareness about the importance of non-pharmacological options for managing PCOS and infertility.
  • By fostering awareness, collaboration, and innovative solutions, the company aims to make a lasting impact on women's reproductive health and well-being.

Lo.Li. Pharma International and its International Partners Achieve a New World Record to Raise Awareness About Innovative Options for Managing PCOS and Infertility

Retrieved on: 
Wednesday, June 28, 2023
Inositol, ESHRE, Education, Society for Human Resource Management, Infertility, European Society of Human Reproduction and Embryology, Polycystic ovary syndrome, Patient, PCOS, Diagnosis, Pharmaceutical industry, Medical device, Embryology

The record-breaking event aimed to raise awareness about non-pharmacological options for managing polycystic ovary syndrome (PCOS) and infertility.

Key Points: 
  • The record-breaking event aimed to raise awareness about non-pharmacological options for managing polycystic ovary syndrome (PCOS) and infertility.
  • Inositol, a naturally occurring compound that plays a vital role in cellular signaling, has shown promise in managing PCOS and infertility.
  • This monumental achievement marks a significant step toward raising awareness about the importance of non-pharmacological options for managing PCOS and infertility.
  • By fostering awareness, collaboration, and innovative solutions, the company aims to make a lasting impact on women's reproductive health and well-being.

MD Logic Health and Cynthia Thurlow, NP Launch Inositol

Retrieved on: 
Monday, March 13, 2023
Philosophy, Cognition, Research, NP, Biohacking, Creatine, Hormone, Longevity, Fasting, Sleep, Liver, Kidney, GMP, Science, Intermittency, Partnership, Coffee, Dietary supplement, Pharmaceutical industry, Inositol

MIAMI, March 13, 2023 /PRNewswire-PRWeb/ -- MD Logic Health ("MD Logic,") a leading provider of USA-made professional-grade nutraceuticals and physician-recommended dietary supplements, is excited to announce its second collaboration with Cynthia Thurlow NP, the best-selling author of IF45 The Intermittent Fasting Transformation and the host of Everyday Wellness podcast.

Key Points: 
  • MD Logic Health ("MD Logic,") a leading provider of USA-made professional-grade nutraceuticals and physician-recommended dietary supplements, is excited to announce its second collaboration with Cynthia Thurlow NP.
  • MIAMI, March 13, 2023 /PRNewswire-PRWeb/ -- MD Logic Health ("MD Logic,") a leading provider of USA-made professional-grade nutraceuticals and physician-recommended dietary supplements, is excited to announce its second collaboration with Cynthia Thurlow NP, the best-selling author of IF45 The Intermittent Fasting Transformation and the host of Everyday Wellness podcast.
  • Cynthia Thurlow, NP expressed her enthusiasm for this partnership, stating, "I am so thrilled to announce the launch of my second product, Inositol, in collaboration with MD Logic Health.
  • The latest product developed under this collaboration is Inositol by Cynthia Thurlow, powered by MD Logic Health.

Pervistop®, the once-daily supplement specifically designed to manage persistent HPV, is now available for exclusive distribution rights worldwide.

Retrieved on: 
Tuesday, November 1, 2022
Marketing, EGCG, United Nations Foundation, Gynaecology, Partnership, General manager, Cancer, National Foundation for Infectious Diseases, Research, Disease, Medical device, Human papillomavirus infection, HPV, Shijiazhuang Pharma Group, Infection, Wart, Woman, Cervical cancer, Patient, Man, Grammatical mood, Functional, Inositol, Fine chemical

FRANKFURT, Germany, Nov. 1, 2022 /PRNewswire/ -- Lo.Li. Pharma International announces the pre-launch of a new, highly anticipated product at CPHI 2022, fulfilling a latent unmet clinical need for patients with the Human Papilloma Virus (HPV). As the largest pharma industry event worldwide, CPHI Frankfurt will allow thousands of participants to have a first look at this innovative product, whose exclusive formula helps to counteract the signs, symptoms, and persistence of HPV.

Key Points: 
  • Pharma International to unveil an innovative new product at CPHI Frankfurt, which has already gained the interest of numerous distribution partners.
  • Pervistop promises to be an extremely effective tool in the management of an exceedingly unpredictable disease.
  • HPV is the most common sexually transmitted infection worldwide, and it is known to cause certain cancers and genital warts.
  • Pharma International is committed to supporting our Partners through equitable, exclusive distribution agreements, while sharing the scientific know-how and marketing strategies, which are needed to be successful.

Pervistop®, the once-daily supplement specifically designed to manage persistent HPV, is now available for exclusive distribution rights worldwide.

Retrieved on: 
Tuesday, November 1, 2022
Marketing, EGCG, United Nations Foundation, Gynaecology, Partnership, General manager, Cancer, National Foundation for Infectious Diseases, Research, Disease, Medical device, Human papillomavirus infection, HPV, Shijiazhuang Pharma Group, Infection, Wart, Woman, Cervical cancer, Patient, Man, Grammatical mood, Functional, Inositol, Fine chemical

FRANKFURT, Germany, Nov. 1, 2022 /PRNewswire/ -- Lo.Li. Pharma International announces the pre-launch of a new, highly anticipated product at CPHI 2022, fulfilling a latent unmet clinical need for patients with the Human Papilloma Virus (HPV). As the largest pharma industry event worldwide, CPHI Frankfurt will allow thousands of participants to have a first look at this innovative product, whose exclusive formula helps to counteract the signs, symptoms, and persistence of HPV.

Key Points: 
  • Pharma International to unveil an innovative new product at CPHI Frankfurt, which has already gained the interest of numerous distribution partners.
  • Pervistop promises to be an extremely effective tool in the management of an exceedingly unpredictable disease.
  • HPV is the most common sexually transmitted infection worldwide, and it is known to cause certain cancers and genital warts.
  • Pharma International is committed to supporting our Partners through equitable, exclusive distribution agreements, while sharing the scientific know-how and marketing strategies, which are needed to be successful.

PCOS Severity Is Linked to Insulin Resistance -- and Gynov Can Help

Retrieved on: 
Thursday, September 29, 2022
PCOS, Health, Incidence, Woman, Insulin resistance, Vaginal bleeding, Plasma protein binding, Infertility, Polycystic ovary syndrome, Polycystic disease, Folliculogenesis, Female, Pathology, Folate, Dietary supplement, Inositol, Gestational diabetes, Birth control, MD

FORT LAUDERDALE, Fla., Sept. 29, 2022 /PRNewswire/ -- PCOS (Polycystic Ovary Syndrome) is a prevalent female health concern. As much as 12% of American women suffer from the condition, and it is one of the most common causes of infertility. While PCOS is something millions of women across the nation struggle with, it's possible to address the issue through a basic study of the root cause — something that the French health company Gynov has been doing for years now.

Key Points: 
  • Gynov has created its groundbreaking product Gynositolas a way to manage the most severe symptoms of PCOS by focusing on a key area: insulin resistance.
  • Studies have shown that the degree of insulin resistance in a woman's body correlates with the severity of their PCOS symptoms specifically the degree of disturbance in their menstrual cyclicity .
  • In other words, if vaginal bleeding is disrupted or irregular, it points to a more severe case of PCOS.
  • "It restores ovarian function, improves oocyte quality, and helps reduce insulin resistance and therefore gestational diabetes incidence and severity."